Mediately
Series A in 2022
Mediately is a prominent medical app company in Central and Eastern Europe and Italy, dedicated to supporting healthcare professionals with essential drug information, clinical decision support tools, and accredited medical education. Operating in eight countries, including Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, and Italy, the company has earned the trust of over 180,000 doctors and more than 200,000 other healthcare professionals who rely on its apps as daily medical assistants. Mediately's platform provides comprehensive, evidence-based information on medications, including ingredients, pricing, interactions, dosing, insurance, and reimbursement, all in the local language of each market. The apps are certified as medical devices in the EU, and the company adheres to strict quality management standards, including EN ISO 13485:2016, to ensure the highest level of service and patient care.
Mediately
Seed Round in 2019
Mediately is a prominent medical app company in Central and Eastern Europe and Italy, dedicated to supporting healthcare professionals with essential drug information, clinical decision support tools, and accredited medical education. Operating in eight countries, including Slovenia, Croatia, Serbia, Czechia, Slovakia, Romania, Bulgaria, and Italy, the company has earned the trust of over 180,000 doctors and more than 200,000 other healthcare professionals who rely on its apps as daily medical assistants. Mediately's platform provides comprehensive, evidence-based information on medications, including ingredients, pricing, interactions, dosing, insurance, and reimbursement, all in the local language of each market. The apps are certified as medical devices in the EU, and the company adheres to strict quality management standards, including EN ISO 13485:2016, to ensure the highest level of service and patient care.